A carregar...
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer
DNA methylation and histone acetylation are two well known epigenetic chromatin modifications. Epigenetic agents leading to DNA hypomethylation and histone hyperacetylation have been approved for treatment of hematological disorders. The first histone deacetylase inhibitor, vorinostat, has been lice...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2695818/ https://ncbi.nlm.nih.gov/pubmed/19486511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-2-22 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|